SURPASS-CVOT
Research into new drug (tirzepatide) for type 2 diabetes and heart disease, compared to dulaglutide.
The 3R Study (Ready to Reduce Risk)
A trial to investigate the effect of structured education on people at high risk of cardiovascular disease